CAS 108061-03-6
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
Ketorolac Ethyl Ester (Ethyl 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H17NO3Couleur et forme :Off-White SolidMasse moléculaire :283.12084Ketorolac EP Impurity J
CAS :Formule :C17H17NO3Couleur et forme :Off-White SolidMasse moléculaire :283.33Ethyl (1RS)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate (Ketorolac Ethyl Ester)
CAS :Produit contrôléFormule :C17H17NO3Couleur et forme :NeatMasse moléculaire :283.32Ketorolac Ethyl Ester (Racemic)
CAS :Produit contrôlé<p>Applications Ethyl-(5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic (cas# 108061-03-6) is a useful research chemical.<br></p>Formule :C17H17NO3Couleur et forme :NeatMasse moléculaire :283.32Ethyl-(5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic
CAS :<p>Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) is a molecule that can be used in the treatment of cardiac diseases. It is a cardiotonic agent that has been shown to shorten the duration of ventricular fibrillation and restore contractility. This drug also decreases the frequency and severity of angina pectoris and enhances coronary artery blood flow. The most effective dose for this drug is 1.5 mg per kg body weight. It is administered orally or intravenously and should not be used with fatty esters because it may cause hypotension. Ethyl (5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate, racemic) has been shown to have an effect on metal coordination profiles as well as an activated form of the molecule.</p>Formule :C17H17O3NDegré de pureté :Min. 98 Area-%Couleur et forme :Off-White PowderMasse moléculaire :283.32 g/mol
